SOS
EBS icon

Silver Oak Securities’s Emergent Biosolutions EBS Stock Holding History

Silver Oak Securities’s Portfolio EBS Stock Details EBS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$929K Buy
110,862
+4,162
+4% +$34.8K 0.06% 313
2026
Q1 		$886K Hold
106,700
– – 0.06% 290
2025
Q4 		$1.3M Hold
106,700
– – 0.09% 227
2025
Q3 		$941K Buy
+106,700
New +$830K 0.07% 276

Other funds holding EBS

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
American Century Companies
American Century Companies Kansas City, Missouri $226B AUM 44.75% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
LSV Asset Management
LSV Asset Management Chicago, Illinois $55.1B AUM 45.38% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $751B AUM 38.74% 1-Year Est. Return
OHA
Oak Hill Advisors New York $701M AUM 78.4% 1-Year Est. Return

Silver Oak Securities's EBS Position: Q2 2026 in Review

Silver Oak Securities increased its Emergent Biosolutions (EBS) stake by 3.9% in Q2 2026, buying an estimated $34.8K and bringing the position to 110,862 shares worth $929K. The position accounts for 0.06% of the portfolio, ranked #313.

Silver Oak Securities first reported a position in EBS in Q3 2025 and has held it in 4 quarters since. The position peaked at $1.3M in Q4 2025. 195 funds tracked by Wall St. Rank hold EBS as of Q2 2026.

  • Silver Oak Securities held 110,862 shares of Emergent Biosolutions worth $929K as of Q2 2026.
  • Silver Oak Securities bought 4,162 Emergent Biosolutions shares in Q2 2026, an estimated $34.8K.
  • Emergent Biosolutions made up 0.06% of Silver Oak Securities's portfolio in Q2 2026, its #313 holding.
  • Silver Oak Securities first reported a position in Emergent Biosolutions in Q3 2025 and has held it in 4 quarters since.
  • Silver Oak Securities's Emergent Biosolutions position peaked at $1.3M in Q4 2025.
  • 195 funds tracked by Wall St. Rank held Emergent Biosolutions as of Q2 2026.

Based on Silver Oak Securities's 13F filing for Q2 2026, filed 7 Aug 2026.